Related Experiment Video
Updated: Dec 3, 2025

Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics
Published on: May 14, 2016
Transmembrane and Immunoglobulin Domain Containing 1, a Putative Tumor Suppressor, Induces G2/M Cell Cycle Checkpoint
Kyle O C De La Cena1, Rachel X-Y Ho1, Razie Amraei1
1Department of Pathology, School of Medicine, Boston University Medical Campus, Boston, Massachusetts.
Abstract:
Colorectal cancer (CRC) is a leading nonfamilial cause of cancer mortality among men and women. Although various genetic and epigenetic mechanisms have been identified, the full molecular mechanisms deriving CRC tumorigenesis are not fully understood. This study demonstrates that cell adhesion molecule transmembrane and immunoglobulin domain containing 1 (TMIGD1) are highly expressed in mouse and human normal intestinal epithelial cells. TMIGD1 knockout mice were developed, and the loss of TMIGD1 in mice was shown to result in the development of adenomas in small intestine and colon. In addition, the loss of TMIGD1 significantly impaired intestinal epithelium brush border membrane, junctional polarity, and maturation. Mechanistically, TMIGD1 inhibits tumor cell proliferation and cell migration, arrests cell cycle at the G2/M phase, and induces expression of p21CIP1 (cyclin-dependent kinase inhibitor 1), and p27KIP1 (cyclin-dependent kinase inhibitor 1B) expression, key cell cycle inhibitor proteins involved in the regulation of the cell cycle. Moreover, TMIGD1 is shown to be progressively down-regulated in sporadic human CRC, and its downregulation correlates with poor overall survival. The findings herein identify TMIGD1 as a novel tumor suppressor gene and provide new insights into the pathogenesis of colorectal cancer and a novel potential therapeutic target.
Insights
The cell adhesion molecule TMIGD1 acts as a tumor suppressor in colorectal cancer (CRC). Loss of TMIGD1 promotes adenoma formation and impairs intestinal epithelium, highlighting its crucial role in CRC pathogenesis.
Area of Science:
- Oncology
- Molecular Biology
- Gastroenterology
Background:
- Colorectal cancer (CRC) remains a significant cause of cancer mortality.
- The complete molecular mechanisms driving CRC tumorigenesis are not fully elucidated.
- Understanding novel genetic and epigenetic factors is crucial for CRC research.
Purpose of the Study:
- To investigate the role of cell adhesion molecule TMIGD1 in colorectal cancer.
- To determine the molecular mechanisms by which TMIGD1 influences intestinal epithelium and tumor development.
- To evaluate TMIGD1 as a potential therapeutic target for CRC.
Main Methods:
- Generation and analysis of TMIGD1 knockout mice.
- Assessment of intestinal epithelium morphology, polarity, and maturation.
- Evaluation of cell proliferation, migration, and cell cycle progression.
- Analysis of p21CIP1 and p27KIP1 expression.
- Correlation analysis of TMIGD1 expression with human CRC patient data.
Main Results:
- TMIGD1 is highly expressed in normal intestinal epithelial cells but downregulated in sporadic human CRC.
- Loss of TMIGD1 in mice led to the development of intestinal adenomas.
- TMIGD1 deficiency impaired intestinal brush border membrane, junctional polarity, and maturation.
- TMIGD1 inhibits tumor cell proliferation and migration, arresting the cell cycle at G2/M phase.
- Downregulation of TMIGD1 correlated with poor patient survival.
Conclusions:
- TMIGD1 functions as a novel tumor suppressor gene in colorectal cancer.
- TMIGD1 plays a critical role in maintaining intestinal epithelial integrity and function.
- TMIGD1 represents a potential therapeutic target for colorectal cancer treatment.
Related Concept Videos
Negative Regulator Molecules
The Cell Cycle Control System
Cyclins and cyclin-dependent kinases (Cdks) are the primary cell cycle regulators and...
The Cell Cycle Control System
Inhibition of Cdk Activity
Abnormal Proliferation
DNA Damage can Stall the Cell Cycle

